Precision Oncology and Cancer Biomarkers
eBook - ePub

Precision Oncology and Cancer Biomarkers

Issues at Stake and Matters of Concern

  1. English
  2. ePUB (mobile friendly)
  3. Available on iOS & Android
eBook - ePub

Precision Oncology and Cancer Biomarkers

Issues at Stake and Matters of Concern

About this book

This open access book reflects on matters of social and ethical concern raised in the daily practices of those working in and around precision oncology. Each chapter addresses the experiences, concerns and issues at stake for people who work in settings where precision oncology is practiced, enacted, imagined or discussed. It subsequently discusses and analyses bioethical dilemmas, scientific challenges and economic trade-offs, the need for new policies, further technological innovation, social work, as well as phenomenological research.

This volume takes a broad actor-centred perspective as, whenever cancer is present, the range of actors with issues at stake appears almost unlimited. This perspective and approach opens up the possibility for further in-depth and diverse questions, posed by the actors themselves, such as: How are cancer researchers navigating biological uncertainties? How do clinicians and policy-makers address ethical dilemmas around prioritisationof care? What are the patients' experiences with, and hopes for, precision oncology? How do policy-makers and entrepreneurs envisage precision oncology? These questions are of great interest to a broad audience, including cancer researchers, oncologists, policy-makers, medical ethicists and philosophers, social scientists, patients and health economists.


Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Precision Oncology and Cancer Biomarkers by Anne Bremer,Roger Strand in PDF and/or ePUB format, as well as other popular books in Medicine & Pharmaceutical, Biotechnology & Healthcare Industry. We have over one million books available in our catalogue for you to explore.

Table of contents

  1. Cover
  2. Front Matter
  3. Introduction
  4. Introduction to the Imaginary of Precision Oncology
  5. Precision Oncology in the News
  6. Cancer Currencies: Making and Marketing Resources in a First-in-Human Drug Trial in Denmark
  7. “Reconstruction of Trouble”
  8. Lost in Translation
  9. HER2 Revisited: Reflections on the Future of Cancer Biomarker Research
  10. The Dynamics of the Labelling Game: An Essay On FLT3 Mutated Acute Myeloid Leukaemia
  11. Crossing the Styx: If Precision Medicine Were to Become Exact Science
  12. Publication Bias in Precision Oncology and Cancer Biomarker Research; Challenges and Possible Implications
  13. Assessing the Cost-Effectiveness of Molecular Targeted Therapies and Immune Checkpoint Inhibitors
  14. Real-World Data in Health Technology Assessment: Do We Know It Well Enough?
  15. Just Caring: Precision Health vs. Ethical Ambiguity: Can we Afford the Ethical and Economic Costs?
  16. Rationing of Personalised Cancer Drugs: Rethinking the Co-production of Evidence and Priority Setting Practices
  17. Filled with Desire, Perceive Molecules
  18. Conclusions: The Biomarkers That Could Be Born
  19. Back Matter